Inozyme Begin Period Cash Flow vs Change In Cash Analysis

INZY Stock  USD 2.92  0.10  3.31%   
Inozyme Pharma financial indicator trend analysis is infinitely more than just investigating Inozyme Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inozyme Pharma is a good investment. Please check the relationship between Inozyme Pharma Begin Period Cash Flow and its Change In Cash accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inozyme Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Inozyme Stock please use our How to Invest in Inozyme Pharma guide.

Begin Period Cash Flow vs Change In Cash

Begin Period Cash Flow vs Change In Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inozyme Pharma Begin Period Cash Flow account and Change In Cash. At this time, the significance of the direction appears to have pay attention.
The correlation between Inozyme Pharma's Begin Period Cash Flow and Change In Cash is -0.99. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Change In Cash in the same time period over historical financial statements of Inozyme Pharma, assuming nothing else is changed. The correlation between historical values of Inozyme Pharma's Begin Period Cash Flow and Change In Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Inozyme Pharma are associated (or correlated) with its Change In Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change In Cash has no effect on the direction of Begin Period Cash Flow i.e., Inozyme Pharma's Begin Period Cash Flow and Change In Cash go up and down completely randomly.

Correlation Coefficient

-0.99
Relationship DirectionNegative 
Relationship StrengthSignificant

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Change In Cash

Most indicators from Inozyme Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inozyme Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inozyme Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Inozyme Stock please use our How to Invest in Inozyme Pharma guide.Selling General Administrative is likely to drop to about 14.5 M in 2024. Issuance Of Capital Stock is likely to drop to about 63.3 M in 2024
 2021 2022 2023 2024 (projected)
Interest Income211K1.9M4.1M4.3M
Net Interest Income211K1.9M4.1M4.3M

Inozyme Pharma fundamental ratios Correlations

0.960.950.980.970.85-0.05-0.880.740.420.80.870.781.00.780.891.0-0.730.940.90.84-0.630.870.991.01.0
0.961.00.930.930.90.15-0.940.70.180.690.890.610.950.750.940.96-0.730.960.890.91-0.610.890.950.960.95
0.951.00.950.940.940.12-0.930.750.20.730.920.630.940.710.910.95-0.780.960.880.9-0.680.880.950.950.94
0.980.930.951.00.91-0.16-0.830.850.480.880.950.830.970.670.810.97-0.860.930.840.81-0.790.820.990.960.96
0.970.930.941.00.91-0.18-0.810.860.490.890.950.830.970.630.80.97-0.870.910.810.79-0.790.820.990.960.95
0.850.90.940.910.910.03-0.810.860.20.770.970.640.840.530.720.86-0.90.890.770.82-0.830.810.880.840.83
-0.050.150.12-0.16-0.180.03-0.38-0.42-0.88-0.54-0.17-0.61-0.060.320.32-0.030.290.170.280.420.350.02-0.080.0-0.01
-0.88-0.94-0.93-0.83-0.81-0.81-0.38-0.57-0.03-0.55-0.77-0.48-0.88-0.89-0.93-0.890.6-0.97-0.97-0.980.49-0.8-0.86-0.9-0.89
0.740.70.750.850.860.86-0.42-0.570.60.950.950.860.730.350.440.73-0.960.740.570.56-0.950.640.780.70.69
0.420.180.20.480.490.2-0.88-0.030.60.770.410.870.430.150.050.39-0.460.230.17-0.03-0.490.260.420.370.39
0.80.690.730.880.890.77-0.54-0.550.950.770.890.970.80.450.470.79-0.880.730.610.51-0.860.680.830.770.77
0.870.890.920.950.950.97-0.17-0.770.950.410.890.780.860.520.690.88-0.940.880.740.76-0.890.80.90.850.84
0.780.610.630.830.830.64-0.61-0.480.860.870.970.780.780.490.440.76-0.760.660.580.43-0.740.630.790.740.75
1.00.950.940.970.970.84-0.06-0.880.730.430.80.860.780.790.891.0-0.720.940.90.83-0.620.870.991.01.0
0.780.750.710.670.630.530.32-0.890.350.150.450.520.490.790.810.78-0.330.840.940.83-0.230.690.720.80.81
0.890.940.910.810.80.720.32-0.930.440.050.470.690.440.890.810.9-0.490.890.880.89-0.360.780.870.920.91
1.00.960.950.970.970.86-0.03-0.890.730.390.790.880.761.00.780.9-0.730.940.90.84-0.630.890.991.01.0
-0.73-0.73-0.78-0.86-0.87-0.90.290.6-0.96-0.46-0.88-0.94-0.76-0.72-0.33-0.49-0.73-0.76-0.59-0.640.99-0.56-0.8-0.7-0.69
0.940.960.960.930.910.890.17-0.970.740.230.730.880.660.940.840.890.94-0.760.960.96-0.670.820.940.940.94
0.90.890.880.840.810.770.28-0.970.570.170.610.740.580.90.940.880.9-0.590.960.95-0.50.770.870.910.91
0.840.910.90.810.790.820.42-0.980.56-0.030.510.760.430.830.830.890.84-0.640.960.95-0.550.690.840.860.85
-0.63-0.61-0.68-0.79-0.79-0.830.350.49-0.95-0.49-0.86-0.89-0.74-0.62-0.23-0.36-0.630.99-0.67-0.5-0.55-0.44-0.71-0.6-0.59
0.870.890.880.820.820.810.02-0.80.640.260.680.80.630.870.690.780.89-0.560.820.770.69-0.440.840.870.87
0.990.950.950.990.990.88-0.08-0.860.780.420.830.90.790.990.720.870.99-0.80.940.870.84-0.710.840.990.99
1.00.960.950.960.960.840.0-0.90.70.370.770.850.741.00.80.921.0-0.70.940.910.86-0.60.870.991.0
1.00.950.940.960.950.83-0.01-0.890.690.390.770.840.751.00.810.911.0-0.690.940.910.85-0.590.870.991.0
Click cells to compare fundamentals

Inozyme Pharma Account Relationship Matchups

Inozyme Pharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets47.9M169.4M123.5M139.2M200.8M132.8M
Other Current Liab2.3M6.9M7.8M10.5M11.7M7.5M
Total Current Liabilities3.2M10.0M11.6M14.7M14.7M10.4M
Total Stockholder Equity(33.2M)158.1M109.3M118.6M140.5M87.9M
Net Tangible Assets(33.2M)158.1M109.3M118.4M136.2M74.5M
Property Plant And Equipment Net298K2.6M4.4M3.6M2.6M2.5M
Net Debt(31.6M)(158.6M)(19.9M)(26.1M)12.0M12.6M
Retained Earnings(34.7M)(91.1M)(147.7M)(214.8M)(285.9M)(271.6M)
Accounts Payable901K3.1M2.4M2.5M1.2M2.0M
Cash31.6M159.9M23.3M32.9M34.6M42.4M
Non Current Assets Total484K18.4M8.2M7.8M4.6M7.3M
Non Currrent Assets Other56K3.5M3.4M3.8M2.0M2.4M
Cash And Short Term Investments47.1M159.9M111.8M127.9M188.6M124.4M
Net Receivables104K155K62K115K385K404.3K
Common Stock Shares Outstanding15.2M23.4M23.6M37.8M51.8M30.6M
Short Term Investments15.5M119.7M88.5M95.0M154.0M88.0M
Liabilities And Stockholders Equity47.9M169.4M123.5M139.4M200.8M132.8M
Non Current Liabilities Total77.9M1.3M2.6M6.1M45.7M25.2M
Capital Surpluse1.4M249.2M256.9M333.4M383.4M402.5M
Other Current Assets224K3.3M3.5M3.4M7.3M7.6M
Other Stockholder Equity(76.5M)79.8M256.9M333.4M426.4M447.7M
Total Liab81.2M11.3M14.3M20.8M60.4M32.7M
Net Invested Capital(33.2M)158.1M109.3M122.5M185.2M96.8M
Total Current Assets47.5M151.0M115.3M131.4M196.3M125.5M
Accumulated Other Comprehensive Income5K2K18K(205K)41K43.1K
Net Working Capital44.2M141.0M103.7M116.7M181.6M115.1M
Property Plant Equipment298K2.6M4.4M2.0M2.3M2.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Inozyme Stock Analysis

When running Inozyme Pharma's price analysis, check to measure Inozyme Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme Pharma is operating at the current time. Most of Inozyme Pharma's value examination focuses on studying past and present price action to predict the probability of Inozyme Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme Pharma's price. Additionally, you may evaluate how the addition of Inozyme Pharma to your portfolios can decrease your overall portfolio volatility.